Loading...
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....
Na minha lista:
| Udgivet i: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Japanese Society of Internal Medicine
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8024946/ https://ncbi.nlm.nih.gov/pubmed/33087674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5930-20 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|